Uniphar appoints industry leader, Isaac Batley, as Global Head of Scientific Communications
January 16, 2025 | Branding, Creative and Design, Digital Communications, Equitable access, Health policy and government affairs, Market Access, Medical Communications, Patient support and adherence, Sales, cell and gene therapy, clinical research, medical education, pharmacy, regulatory affairs
Isaac Batley, an experienced CEO with 35 years’ experience within healthcare and pharmaceutical communications, joins Uniphar to spearhead its medical communications division.
[Dublin 16th January 2025] Uniphar, a leading global partner to pharmaceutical and medtech manufacturers, announces the appointment of Isaac Batley as Global Head of Medical and Scientific Communications. In this pivotal role, Isaac will lead the growth of Uniphar’s medical communications capabilities, harnessing his 35 years of leadership experience working in healthcare communications within the pharmaceutical sector.
Isaac’s career includes serving as Chief Executive Officer at SCIRIS where he scaled the medical communications division globally, and heading-up the European Leadership Team at Cello Health before becoming Chairman of the communications agency. Prior to this, Isaac built and sold his own medical communications agency and held a Director-level role at Quintiles working specifically in clinical trials for the NHS.
Isaac spent the first part of his career working with AstraZeneca, Sanofi and Pfizer and his experience and expertise positions him to advance Uniphar’s medical communications, focusing on integrating scientific insights to benefit healthcare professionals, patients, and stakeholders.
Isaac will collaborate closely with key leaders across Uniphar, including Director of Medical Affairs, Maurice Leonard, Managing Director of Access, Dan Piggot, and Managing Director of Commercial, Karl Hamer, to ensure an integrated approach and cohesive medical communications strategy.
Commenting on his appointment, Isaac said: “Medical communications is the unifying thread that ties together the extensive service areas and capabilities that Uniphar has to offer. It touches every aspect of the organization and presents an exciting opportunity to bring these capabilities together in a way that delivers impactful and meaningful results. My remit will cover the whole organization, working to integrate and present Uniphar’s expertise in new and innovative ways.”
The appointment reinforces Uniphar’s ongoing commitment to bringing complex medicines to complex markets, and ensuring an expert team of industry leaders to deliver specialist services to more than 200 international clients across 180 countries.
“Isaac brings a unique perspective and extensive experience that aligns with our mission to transform patient access to medicines. As Uniphar continues to scale globally, Isaac’s leadership and strategic vision will be instrumental in supporting our continued development and growth,” says Brian O’Shaughnessy, Chief Commercial Officer at Uniphar.
For more information on Uniphar, visit www.Uniphar.com/Pharma
ENDS
For media enquiries, please contact:
Heather Hopkin at TALA at heather.hopkin@teamtala.com
Beth O’Shea at TALA at beth.oshea@teamtala.com
About Uniphar
Uniphar Group is a trusted global partner to pharma, medtech and biotech companies, working to improve patient access to medicines around the world. Uniphar’s team of experts harness the capabilities, infrastructure and expertise of a diversified pharmaceutical service provider with more than 55 years’ building success stories with 200+ multinational clients.
Our understanding of the shifting market dynamics allows us to deliver tailored specialist services and solutions for our clients’ changing needs. Uniphar Pharma comprises
Uniphar | Access, Uniphar | Medical, and Uniphar | Commercial – together our combined capabilities make us your trusted partner to unlock access for your patients to innovative therapies and optimize value for brands globally. Working from clinical development to commercialization, our end-to-end services remove barriers to launch, increase access and optimize brands.
This content was provided by Uniphar
Company Details
Latest Content from Uniphar
Uniphar appoints industry leader, Isaac Batley, as Global Head of Scientific Communications
Isaac Batley, an experienced CEO with 35 years’ experience within healthcare and pharmaceutical communications, joins Uniphar to spearhead its medical communications division.
From molecule to market and beyond: Uniphar announces extended global commercialization platform
Healthcare services business, Uniphar, has developed its full-service offering that harnesses Uniphar’s 57 years in the industry delivering specialist services to more than 200 international clients across 180 countries.
- 1
- 2